Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Aug;22(4):453-8.
doi: 10.1007/BF02773813.

Production of lymphokines by HBsAg-reactive human T cell clones upon antigenic stimulation

Affiliations

Production of lymphokines by HBsAg-reactive human T cell clones upon antigenic stimulation

A Nonomura et al. Gastroenterol Jpn. 1987 Aug.

Abstract

The production of lymphokines by human HBsAg-reactive T cell clones was examined. The five clones were successfully obtained from an HBV-vaccinated person and were composed exclusively of Leu 1+, Leu 2a, Leu 3a+, helper/inducer T cells. Three of the five showed significant levels of gamma interferon (IFN-gamma) production and all of the five produced B cell growth factor (BCGF) by stimulation with HBsAg but not with unrelated antigens, including influenza A virus antigens and PPD, whereas no detectable amount of interleukin-2 was found in all clone supernatants. The magnitude of HBsAg-induced cell proliferation did not parallel the levels of IFN-gamma production among the clones. These results indicate from the view of lymphokine production that the HBsAg-reactive helper/inducer T cell clones were heterogeneous even from a source of the peripheral blood sample, and further suggest that the clones play important roles in the immune reaction against HBV infection by producing lymphokines upon antigenic stimulation.

PubMed Disclaimer

Similar articles

References

    1. J Immunol. 1978 Jun;120(6):2027-32 - PubMed
    1. Nature. 1981 Nov 19;294(5838):261-3 - PubMed
    1. J Exp Med. 1983 Feb 1;157(2):530-46 - PubMed
    1. Adv Immunol. 1983;34:97-140 - PubMed
    1. Clin Exp Immunol. 1985 Feb;59(2):505-11 - PubMed

Publication types